ATE241993T1 - Zubereitungen zur tumorbehandlung enthaltend hai- knorpelextrakte und antineoplastische mittel - Google Patents

Zubereitungen zur tumorbehandlung enthaltend hai- knorpelextrakte und antineoplastische mittel

Info

Publication number
ATE241993T1
ATE241993T1 AT98907789T AT98907789T ATE241993T1 AT E241993 T1 ATE241993 T1 AT E241993T1 AT 98907789 T AT98907789 T AT 98907789T AT 98907789 T AT98907789 T AT 98907789T AT E241993 T1 ATE241993 T1 AT E241993T1
Authority
AT
Austria
Prior art keywords
cartil
preparations
extracts
antineoplastic agents
tumor treatment
Prior art date
Application number
AT98907789T
Other languages
English (en)
Inventor
Eric Dupont
Original Assignee
Aeterna Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Lab Inc filed Critical Aeterna Lab Inc
Application granted granted Critical
Publication of ATE241993T1 publication Critical patent/ATE241993T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98907789T 1997-03-11 1998-03-11 Zubereitungen zur tumorbehandlung enthaltend hai- knorpelextrakte und antineoplastische mittel ATE241993T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2199694 1997-03-11
PCT/CA1998/000202 WO1998040088A1 (en) 1997-03-11 1998-03-11 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents

Publications (1)

Publication Number Publication Date
ATE241993T1 true ATE241993T1 (de) 2003-06-15

Family

ID=4160148

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907789T ATE241993T1 (de) 1997-03-11 1998-03-11 Zubereitungen zur tumorbehandlung enthaltend hai- knorpelextrakte und antineoplastische mittel

Country Status (18)

Country Link
US (2) US6383522B1 (de)
EP (1) EP0967987B1 (de)
JP (1) JP2001500899A (de)
KR (1) KR100417612B1 (de)
CN (2) CN1245993C (de)
AT (1) ATE241993T1 (de)
AU (1) AU745769B2 (de)
BR (1) BR9808858A (de)
CA (1) CA2281570C (de)
DE (1) DE69815310T2 (de)
DK (1) DK0967987T3 (de)
ES (1) ES2200316T3 (de)
IL (1) IL131701A (de)
NO (1) NO322847B1 (de)
NZ (1) NZ337376A (de)
PT (1) PT967987E (de)
RU (1) RU2195946C2 (de)
WO (1) WO1998040088A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
CA2461227C (en) * 2001-09-24 2012-05-15 Jessie L.-S Au Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US20070010430A1 (en) * 2003-03-20 2007-01-11 Hosokawa Micron Corparation Proteoglycan isolated from cartilaginous fish and process for producing the same
DE04777189T1 (de) * 2003-07-02 2011-04-07 Solux Corporation, San Diego Thermisch stabiles kristallines epirubicin-hydrochlorid und herstellungsverfahren dafür
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
WO2006059236A2 (en) * 2004-11-16 2006-06-08 Aeterna Zentaris Inc. Method of using cartilage extract for increasing blood parameters
EP2295080A3 (de) 2005-07-25 2011-06-22 Emergent Product Development Seattle, LLC B-Zell-Verringerung mit CD37-spezifischen und CD20-spezifischen Bindungsmolekülen
EP1930017B1 (de) 2005-09-29 2012-05-23 Maruha Nichiro Seafoods, Inc. Zusammensetzung zur prävention und behandlung von krankheiten von erwachsenen
CN105837690A (zh) 2006-06-12 2016-08-10 新兴产品开发西雅图有限公司 具有效应功能的单链多价结合蛋白
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
CN101990439A (zh) * 2007-07-06 2011-03-23 特鲁比昂药品公司 具有置于c末端的特异性结合结构域的结合肽
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
PT2132228E (pt) * 2008-04-11 2011-10-11 Emergent Product Dev Seattle Imunoterapia de cd37 e sua combinação com um quimioterápico bifuncional
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
KR102784293B1 (ko) 2015-09-21 2025-03-20 압테보 리서치 앤드 디벨롭먼트 엘엘씨 Cd3 결합 폴리펩타이드
WO2017201200A1 (en) * 2016-05-19 2017-11-23 Orphagen Pharmaceuticals, Inc. Therapeutic compositions containing rar-alpha antagonists

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28093E (en) 1962-02-28 1974-07-30 Wound-healing cartilage powder
US3478146A (en) 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US3966908A (en) 1973-11-29 1976-06-29 Lescarden Ltd. Method of treating degenerative joint afflictions
US4042457A (en) 1975-11-10 1977-08-16 Rush-Presbyterian-St. Luke's Medical Center Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
US4822607A (en) * 1976-10-29 1989-04-18 Lescarden Ltd. Anti-tumor agent and method
US4212857A (en) 1976-10-29 1980-07-15 Lescarden Ltd. Method for stimulating the production of immunoglobulin and total complement
US4243582A (en) 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4350682A (en) 1979-05-11 1982-09-21 Lescarden Ltd. Cartilage extraction processes and products
US4356261A (en) 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
US4456589A (en) 1982-07-08 1984-06-26 Genetic Laboratories, Inc. Preparation of animal tissues for surgical implantation in human recipients
US4473551A (en) 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
JPS5939828A (ja) 1982-08-28 1984-03-05 Ajinomoto Co Inc 抗腫瘍活性物質の製造方法
US4444752A (en) 1982-09-13 1984-04-24 Lescarden Ltd. Method for treating progressive systemic sclerosis
US4469676A (en) 1983-06-21 1984-09-04 Michel Hecmati Method for eliminating wrinkles occurring in the human skin
JPS60178820A (ja) 1984-02-22 1985-09-12 Ajinomoto Co Inc 抗腫瘍活性物質の製造方法
US4656137A (en) 1985-09-12 1987-04-07 Lescarden Inc Method of processing animal cartilage
US4749522A (en) 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4746729A (en) 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
US5135919A (en) 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
US5096892A (en) 1988-05-27 1992-03-17 The Children's Medical Center Corporation Arylsulfatase inhibition and potentiation of angiostatic steroids and heparin
ES2093699T3 (es) * 1990-01-25 1997-01-01 Childrens Hosp Medical Center Metodo y composiciones para inhibir la angiogenesis.
US5075112A (en) 1990-02-12 1991-12-24 Cartilage Technologies Inc. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
EP0571597A4 (en) 1991-11-15 1994-06-01 Arthro Res & Dev Corp Method for treatment of acute and chronic painful arthropathic conditions in human and other mammals
WO1994012510A1 (en) 1992-11-30 1994-06-09 Lane I William Processing shark cartilage
CN1502331A (zh) 1993-07-19 2004-06-09 Ѫ�ܼ���ҩ�﹫˾ 抗血管生长组合物及使用方法
US6025334A (en) 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US5618925A (en) 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US6028118A (en) 1996-08-08 2000-02-22 Les Laboratoires Aeterna Inc. Methods of using extracts of shark cartilage
RU2066181C1 (ru) * 1994-06-02 1996-09-10 Онкологический научный центр им. Н.Н.Блохина Противоопухолевое средство
US5583153A (en) 1994-10-06 1996-12-10 Regents Of The University Of California Use of taxol in the treatment of rheumatoid arthritis
RU2157695C2 (ru) * 1995-02-03 2000-10-20 Ле Лабораториз Аетерна Инк. Экстракты хрящей акулы, способ их получения и применения
US5843920A (en) 1996-09-16 1998-12-01 Biocell Technology, Llc Anionic saccharides for extraction of anti-angiogenic protein from cartilage
US6168807B1 (en) 1998-07-23 2001-01-02 Les Laboratoires Aeterna Inc. Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof

Also Published As

Publication number Publication date
AU6605598A (en) 1998-09-29
CN1245993C (zh) 2006-03-22
CN1250375A (zh) 2000-04-12
US20020146462A1 (en) 2002-10-10
CA2281570A1 (en) 1998-09-17
US6855338B2 (en) 2005-02-15
JP2001500899A (ja) 2001-01-23
IL131701A0 (en) 2001-03-19
BR9808858A (pt) 2000-08-01
HK1026364A1 (en) 2000-12-15
EP0967987B1 (de) 2003-06-04
RU2195946C2 (ru) 2003-01-10
KR20000075929A (ko) 2000-12-26
AU745769B2 (en) 2002-03-28
ES2200316T3 (es) 2004-03-01
US6383522B1 (en) 2002-05-07
NO994274L (no) 1999-11-09
WO1998040088A1 (en) 1998-09-17
DE69815310T2 (de) 2004-04-22
DE69815310D1 (de) 2003-07-10
DK0967987T3 (da) 2003-09-22
IL131701A (en) 2005-03-20
CN1824317A (zh) 2006-08-30
NO322847B1 (no) 2006-12-11
EP0967987A1 (de) 2000-01-05
CA2281570C (en) 2003-09-23
KR100417612B1 (ko) 2004-02-05
NO994274D0 (no) 1999-09-02
PT967987E (pt) 2003-10-31
NZ337376A (en) 2002-02-01

Similar Documents

Publication Publication Date Title
DE69815310D1 (de) Zubereitungen zur tumorbehandlung enthaltend hai-knorpelextrakte und antineoplastische mittel
SG170612A1 (en) Antineoplastic combinations
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
SG157951A1 (en) Cripto blocking antibodies and uses thereof
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
IL163573A0 (en) Conjugates of therapeutic or cytotoxic agents and biologically active peptides
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
MY138883A (en) Use of asiatic acid for treatment of cencer
DE69905170T2 (de) Thiazolopyrimidinderivate
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
MY164077A (en) Compositions and uses of et743 for treating cancer
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
IL150984A0 (en) Modified cytokines for use in cancer therapy
DE60124387D1 (de) Synergistische kombination zur behandlung von kolorektalkarzinom
BR9814419A (pt) "combinação de compostos de benzociclo-heptapiridina e drogas antineopláticas para tratamento de doenças proliferativas"
FR2765483B1 (fr) Medicament destine a traiter les dysfonctions erectiles
ATE211650T1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
TR200002939T2 (tr) Paroksetin maleat
AU1128801A (en) Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth
GB9723824D0 (en) Cytostatic agents
PL365075A1 (en) Combinations of dalfopristine/quinupristine with cefpirome
MXPA05002477A (es) Asialo-interferones y el tratamiento de cancer de higado.
IT1271292B (it) Composizioni farmaceutiche contenenti melatonina e inibitori dei recettori degli estrogeni

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0967987

Country of ref document: EP

REN Ceased due to non-payment of the annual fee